Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need. Our platform technology focuses on creating long-lasting antitumor immunity by capitalizing on a robust, transient antiviral immune response through a synergy with multiple payload expression. Virogin is designing a more potent oncolytic virus, expressing optimized payloads to enhance the systemic antitumor immunity in relapsed/refractory cancers. Led by our leadership team with over 25 years of experience in fundamental research, translational and clinical development of immunotherapy & oncolytic virotherapy, we are determined to bring our novel therapies for relapsed/refractory cancers to market.
View Top Employees from Virogin BiotechWebsite | https://www.virogin.com/ |
Revenue | $10 million |
Funding | $62 million |
Employees | 56 (56 on RocketReach) |
Founded | 2015 |
Address | 150-13511 Commerce Pkwy, Richmond, British Columbia V6V 2J8, CA |
Phone | (604) 222-0591 |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Business Services General, Drug Discovery, Business Services, Science and Engineering, Health Care |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Virogin Biotech employee's phone or email?
The Virogin Biotech annual revenue was $10 million in 2024.
Jeff Lange is the Executive Vice President Business Development of Virogin Biotech.
56 people are employed at Virogin Biotech.
Virogin Biotech is based in Richmond, British Columbia.
The NAICS codes for Virogin Biotech are [541, 541713, 54, 54171, 5417].
The SIC codes for Virogin Biotech are [873, 87].